1-8 of 8
Hans-Ulrich Schildhaus
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Crizotinib in ROS1 and MET Deregulated NSCLC—Letter

Marcel Wiesweg, Martin Schuler, Hans-Ulrich Schildhaus
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (7): 1774.
https://doi.org/10.1158/1078-0432.CCR-19-3740
Published: 01 April 2020
View articletitled, Crizotinib in ROS1 and MET Deregulated NSCLC—Letter
Open the PDF for Crizotinib in ROS1 and MET Deregulated NSCLC—Letter in another window
Journal Articles

MET–GRB2 Signaling-Associated Complexes Correlate with Oncogenic MET Signaling and Sensitivity to MET Kinase Inhibitors

Matthew A. Smith, Thomas Licata, Aliya Lakhani, Marileila Varella Garcia, Hans-Ulrich Schildhaus, Vincent Vuaroqueaux, Balazs Halmos, Alain C. Borczuk, Y. Ann Chen, Benjamin C. Creelan, Theresa A. Boyle, Eric B. Haura
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (22): 7084–7096.
https://doi.org/10.1158/1078-0432.CCR-16-3006
Published: 14 November 2017
View articletitled, MET–GRB2 Signaling-Associated Complexes Correlate with Oncogenic MET Signaling and Sensitivity to MET Kinase Inhibitors
Open the PDF for MET–GRB2 Signaling-Associated Complexes Correlate with Oncogenic MET Signaling and Sensitivity to MET Kinase Inhibitors in another window
Includes: Supplementary data
Journal Articles

Heterogeneous Mechanisms of Primary and Acquired Resistance to Third-Generation EGFR Inhibitors

Sandra Ortiz-Cuaran, Matthias Scheffler, Dennis Plenker, llona Dahmen, Andreas H. Scheel, Lynnette Fernandez-Cuesta, Lydia Meder, Christine M. Lovly, Thorsten Persigehl, Sabine Merkelbach-Bruse, Marc Bos, Sebastian Michels, Rieke Fischer, Kerstin Albus, Katharina König, Hans-Ulrich Schildhaus, Jana Fassunke, Michaela A. Ihle, Helen Pasternack, Carina Heydt, Christian Becker, Janine Altmüller, Hongbin Ji, Christian Müller, Alexandra Florin, Johannes M. Heuckmann, Peter Nuernberg, Sascha Ansén, Lukas C. Heukamp, Johannes Berg, William Pao, Martin Peifer, Reinhard Buettner, Jürgen Wolf, Roman K. Thomas, Martin L. Sos
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (19): 4837–4847.
https://doi.org/10.1158/1078-0432.CCR-15-1915
Published: 02 October 2016
View articletitled, Heterogeneous Mechanisms of Primary and Acquired Resistance to Third-Generation EGFR Inhibitors
Open the PDF for Heterogeneous Mechanisms of Primary and Acquired Resistance to Third-Generation EGFR Inhibitors in another window
Includes: Supplementary data
Journal Articles

MET Amplification Status in Therapy-Naïve Adeno- and Squamous Cell Carcinomas of the Lung

Hans-Ulrich Schildhaus, Anne M. Schultheis, Josef Rüschoff, Elke Binot, Sabine Merkelbach-Bruse, Jana Fassunke, Wolfgang Schulte, Yon-Dschun Ko, Andreas Schlesinger, Marc Bos, Masyar Gardizi, Walburga Engel-Riedel, Michael Brockmann, Monika Serke, Ulrich Gerigk, Khosro Hekmat, Konrad F. Frank, Marcel Reiser, Holger Schulz, Stefan Krüger, Erich Stoelben, Thomas Zander, Jürgen Wolf, Reinhard Buettner
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2015) 21 (4): 907–915.
https://doi.org/10.1158/1078-0432.CCR-14-0450
Published: 16 February 2015
View articletitled, MET Amplification Status in Therapy-Naïve Adeno- and Squamous Cell Carcinomas of the Lung
Open the PDF for MET Amplification Status in Therapy-Naïve Adeno- and Squamous Cell Carcinomas of the Lung in another window
Journal Articles

Tumor Genotype Is an Independent Prognostic Factor in Primary Gastrointestinal Stromal Tumors of Gastric Origin: A European Multicenter Analysis Based on ConticaGIST

Agnieszka Wozniak, Piotr Rutkowski, Patrick Schöffski, Isabelle Ray-Coquard, Isabelle Hostein, Hans-Ulrich Schildhaus, Axel Le Cesne, Elzbieta Bylina, Janusz Limon, Jean-Yves Blay, Janusz A. Siedlecki, Eva Wardelmann, Raf Sciot, Jean-Michel Coindre, Maria Debiec-Rychter
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2014) 20 (23): 6105–6116.
https://doi.org/10.1158/1078-0432.CCR-14-1677
Published: 30 November 2014
View articletitled, Tumor Genotype Is an Independent Prognostic Factor in Primary Gastrointestinal Stromal Tumors of Gastric Origin: A European Multicenter Analysis Based on ConticaGIST
Open the PDF for Tumor Genotype Is an Independent Prognostic Factor in Primary Gastrointestinal Stromal Tumors of Gastric Origin: A European Multicenter Analysis Based on ConticaGIST in another window
Includes: Supplementary data
Journal Articles

Therapeutic Consequences from Molecular Biology for Gastrointestinal Stromal Tumor Patients Affected by Neurofibromatosis Type 1

Chiara Mussi, Hans-Ulrich Schildhaus, Alessandro Gronchi, Eva Wardelmann, Peter Hohenberger
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (14): 4550–4555.
https://doi.org/10.1158/1078-0432.CCR-08-0086
Published: 15 July 2008
View articletitled, Therapeutic Consequences from Molecular Biology for Gastrointestinal Stromal Tumor Patients Affected by Neurofibromatosis Type 1
Open the PDF for Therapeutic Consequences from Molecular Biology for Gastrointestinal Stromal Tumor Patients Affected by Neurofibromatosis Type 1 in another window
Journal Articles

Polyclonal Resistance in Gastrointestinal Stromal Tumor Treated with Sequential Kinase Inhibitors

Eva Wardelmann, Katharina Biermann, Sabine Merkelbach-Bruse, Hans-Ulrich Schildhaus, Nadja Thomas, Reinhard Büttner, Torsten Pietsch, Thomas Heinicke, Nicola Speidel, Daniel Pink, Peter Reichardt, Peter Hohenberger
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (20): 6206.
https://doi.org/10.1158/1078-0432.CCR-06-1749
Published: 24 October 2006
View articletitled, Polyclonal Resistance in Gastrointestinal Stromal Tumor Treated with Sequential Kinase Inhibitors
Open the PDF for Polyclonal Resistance in Gastrointestinal Stromal Tumor Treated with Sequential Kinase Inhibitors in another window
Journal Articles

Polyclonal Evolution of Multiple Secondary KIT Mutations in Gastrointestinal Stromal Tumors under Treatment with Imatinib Mesylate

Eva Wardelmann, Sabine Merkelbach-Bruse, Katharina Pauls, Nadja Thomas, Hans-Ulrich Schildhaus, Thomas Heinicke, Nicola Speidel, Torsten Pietsch, Reinhard Buettner, Daniel Pink, Peter Reichardt, Peter Hohenberger
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (6): 1743–1749.
https://doi.org/10.1158/1078-0432.CCR-05-1211
Published: 21 March 2006
View articletitled, Polyclonal Evolution of Multiple Secondary KIT Mutations in Gastrointestinal Stromal Tumors under Treatment with Imatinib Mesylate
Open the PDF for Polyclonal Evolution of Multiple Secondary KIT Mutations in Gastrointestinal Stromal Tumors under Treatment with Imatinib Mesylate in another window